Spermosens AB Statistics

Total Valuation

Spermosens AB has a market cap or net worth of SEK 11.93 million. The enterprise value is 11.50 million.

Market Cap	11.93M
Enterprise Value	11.50M

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Spermosens AB has 1.36 billion shares outstanding. The number of shares has increased by 392.48% in one year.

Current Share Class	n/a
Shares Outstanding	1.36B
Shares Change (YoY)	+392.48%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.40%
Owned by Institutions (%)	2.52%
Float	1.27B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.44
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.13
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.93

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.01.

Current Ratio	0.78
Quick Ratio	0.78
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-8.80

Financial Efficiency

Return on equity (ROE) is -50.97% and return on invested capital (ROIC) is -23.01%.

Return on Equity (ROE)	-50.97%
Return on Assets (ROA)	-20.04%
Return on Invested Capital (ROIC)	-23.01%
Return on Capital Employed (ROCE)	-31.82%
Revenue Per Employee	n/a
Profits Per Employee	-3.40M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.82% in the last 52 weeks. The beta is -0.37, so Spermosens AB's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	-94.82%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	49.03
Average Volume (20 Days)	11,299,411

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.16M
Pretax Income	-10.20M
Net Income	-10.20M
EBITDA	-8.98M
EBIT	-9.16M
Earnings Per Share (EPS)	-0.05

Full Income Statement

Balance Sheet

The company has 659,000 in cash and 229,000 in debt, giving a net cash position of 430,000 or 0.00 per share.

Cash & Cash Equivalents	659,000
Total Debt	229,000
Net Cash	430,000
Net Cash Per Share	0.00
Equity (Book Value)	27.34M
Book Value Per Share	0.10
Working Capital	-494,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.76 million and capital expenditures -4.60 million, giving a free cash flow of -12.36 million.

Operating Cash Flow	-7.76M
Capital Expenditures	-4.60M
Free Cash Flow	-12.36M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Spermosens AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-392.48%
Shareholder Yield	-392.48%
Earnings Yield	-85.50%
FCF Yield	-103.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a